Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
-
5 المنشورات
-
1 الصور
-
0 الفيديوهات
-
يعيش في 191/1, Bir Uttam Mir Shawkat SarakTejgaon C/A,Dhaka-1208, Bangladesh
-
Male
-
متابَع بواسطة 0 أشخاص
التحديثات الأخيرة
-
Generic Ruxolitinib Topical Treatment for Eczema & VitiligoSkin conditions like atopic dermatitis (eczema) and vitiligo are more than just cosmetic concerns; they impact confidence, comfort, and quality of life. For years, patients relied on corticosteroids, which often came with risks of skin thinning and other side effects. The medical field has since evolved, introducing JAK inhibitors as a revolutionary way to treat these conditions at their...0 التعليقات 0 المشاركات 689 مشاهدة 0 معاينةالرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Ventoxen (Venetoclax): Targeted Cancer Therapy for CLL & AMLIn the rapidly evolving landscape of oncology, the shift from broad-spectrum treatments to precision medicine has redefined hope for patients. Among the most significant breakthroughs in recent years is Ventoxen (Venetoclax). As a highly specialized cancer therapy, Ventoxen offers a targeted approach to treating specific hematological malignancies, namely Chronic Lymphocytic Leukemia (CLL) and...0 التعليقات 0 المشاركات 664 مشاهدة 0 معاينة
-
Affordable Resiliva (Resmetirom) for NASH Fibrosis – Buy OnlineNon-alcoholic steatohepatitis (NASH), now increasingly referred to as Metabolic Dysfunction-Associated Steatohepatitis (MASH), has long been a challenge for the medical community. For years, patients struggling with liver inflammation and advancing fibrosis had few direct treatment options beyond lifestyle changes. However, the introduction of Resmetirom, marketed under the brand name Resiliva,...0 التعليقات 0 المشاركات 587 مشاهدة 0 معاينة
-
Cravacin (Deucravacitinib) 6mg: Generic TYK2 Inhibitor for PsoriasisThe landscape of plaque psoriasis treatment has witnessed a revolutionary shift with the introduction of TYK2 inhibitors. For millions of individuals living with moderate-to-severe plaque psoriasis, the daily struggle involves managing itchy, scaly, and often painful skin lesions. While topical creams and traditional systemic treatments have long been the standard, many patients seek a more...0 التعليقات 0 المشاركات 557 مشاهدة 0 معاينة
-
0 التعليقات 0 المشاركات 450 مشاهدة 0 معاينة
المزيد من المنشورات